<DOC>
	<DOCNO>NCT00688298</DOCNO>
	<brief_summary>The pre-pubic approach tension free vaginal sling placement new approach treatment SUI . The retropubic approach tension free vaginal sling standard method device delivery ; addition suprapubic transobturator approach alternative method delivery . All delivery approach system intend place mesh `` tension free '' mid-urethra . There currently study investigate pre-pubic delivery approach United States . However , large series case Europe use pre-pubic system do Ulmsten ( publish European Journal Obstetrics Gynecology Reproductive Biology ) 107 ( 2003 ) 205-207 , title `` Pre-Pubic tension free vaginal tape application : alternative classic tension free vaginal tape application select patient SUI . '' The primary objective study evaluate feasibility use pre-pubic approach placement mid-urethral vaginal mesh . - Demonstrate mesh properly place mid-urethra use pre-pubic approach ; - Assess performance delivery device measure ease use , technical complexity , instrument difficulty</brief_summary>
	<brief_title>Post Market Clinical Study Evaluate Mid-Urethral Vaginal Tape Procedure With Pre-Pubic Delivery Approach , Treatment Stress Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<mesh_term>Imidacloprid</mesh_term>
	<criteria>Female great 18 year age Willing able comply study procedure provide write informed consent participate study Diagnosed genuine SUI confirm urodynamic evaluation ( urodynamic evaluation perform past 6 month acceptable ) document source document patient chart , physician note , nurse note , hospital record , etc . If patient overactive bladder , condition must minor component patient 's disorder demonstrate urodynamic testing . This physician discretion inclusion exclusion study . Patients willing complete ( PFDIshort form 20 ) PISQ12 baseline , 3 month , 6 month 12 month postoperatively . Patient document SUI classification degree hypermobility and/ intrinsic sphincter abnormality ( QTip test ) . Confirm patient 's SUI diagnosis use one follow procedure : Vaginal exam Cough provocation test Cystoscopic exam Patients must negative urine culture Patients ' bladder capacity 350cc Document void diary pre postoperatively Document postvoid residual ( PVR ) equal less 100cc Patients require regional , general anesthesia monitor anesthesia Pad test baseline demonstrate 5 gram great urine loss Patients mentally competent able understand study requirement Patients agree read sign inform consent form prior study related procedure ( screening/ baseline visit ) Patients , clinical judgment investigator , suitable study Patients , investigator 's opinion , mentally legally incapacitate , unable read understand write material , thereby prevent inform consent Patients participate investigational study ( medical device drug ) within 30 day study entry may impact analysis device previously participate current trial Patients pregnant , lactate , plan future pregnancy Patients Diabetes Mellitus type I II Patients vesicourethral reflex , upper urinary tract obstruction , spastic bladder , detrouser muscle instability Patient treat corticosteriod immunosuppresant agent within 90 day preoperatively except patient treat inhaled steroid treatment asthma Patients compromise immune system Patients acute cystitis urethritis Patients previous urinary incontinence procedure Patients previous radiation pelvis Patients coagulopathy and/ currently anticoagulant medication Patients know suspected hypersensitivity mesh Patients complain pelvic pain and/ dyspareunia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>